Ireland[爱尔兰药品]

VFEND 50 mg and 200 mg film-coated tablets.VFEND 200 mg powd

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-12-28 　查阅全文...

NAVELBINE® 20mg soft capsuleVinorelbine tartrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-12-28 　查阅全文...

NAVELBINE® 30mg soft capsuleVinorelbine tartrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-12-28 　查阅全文...

Incruse® 55 micrograms inhalation powder, pre-dispensed

1.Nameofthemedicinalproduct Incruse®55microgramsinhalationpowder,pre-dispensed 2.Qualitativeandquantitativecomposition Eachsingleinhalationprovidesadelivereddose(thedos..

录入者：admin 发表于：2014-12-28 　查阅全文...

PERFALGAN 10 mg/ml solution for infusion.Paracetamol

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2014-12-24 　查阅全文...

RoActemra 20mg/ml Concentrate for Solution for Infusion

1.Nameofthemedicinalproduct RoActemra20mg/mlconcentrateforsolutionforinfusion. 2.Qualitativeandquantitativecomposition Eachmlconcentratecontains20mgtocilizumab*. Each..

录入者：admin 发表于：2014-12-23 　查阅全文...

Mabthera 100mg and 500mg concentrate for solution for infusion

1.Nameofthemedicinalproduct MabThera100mgconcentrateforsolutionforinfusion MabThera500mgconcentrateforsolutionforinfusion 2.Qualitativeandquantitativecomposition Each..

录入者：admin 发表于：2014-12-23 　查阅全文...

MabThera 1400 mg Solution for Subcutaneous Injection

1.Nameofthemedicinalproduct MabThera1400mgsolutionforsubcutaneousinjection 2.Qualitativeandquantitativecomposition EachmLcontains120mgofrituximab. Eachvialcontains140..

录入者：admin 发表于：2014-12-23 　查阅全文...

Velphoro 500 mg chewable tablets

1.Nameofthemedicinalproduct Velphoro500mgchewabletablets 2.Qualitativeandquantitativecomposition Eachchewabletabletcontains500mgironassucroferricoxyhydroxidealsoknownasamix..

录入者：admin 发表于：2014-12-22 　查阅全文...

BindRen 3 g granules

1.Nameofthemedicinalproduct BindRen3ggranules 2.Qualitativeandquantitativecomposition Eachsachetcontains3gcolestilan. Forthefulllistofexcipients,seesection6.1. ..

录入者：admin 发表于：2014-12-22 　查阅全文...

BindRen 2 g granules

1.Nameofthemedicinalproduct BindRen2ggranules 2.Qualitativeandquantitativecomposition Eachsachetcontains2gcolestilan. Forthefulllistofexcipients,seesection6.1. ..

录入者：admin 发表于：2014-12-22 　查阅全文...

BindRen 1 g film-coated tablets

1.Nameofthemedicinalproduct BindRen1gfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachfilm-coatedtabletcontains1gcolestilan. Forthefulllistofexcipients,..

录入者：admin 发表于：2014-12-22 　查阅全文...

Xultophy 100units/ml insulin degludec+3.6mg/mL liraglutide solution..

1.Nameofthemedicinalproduct Xultophy▼100units/mL+3.6mg/mLsolutionforinjection. 2.Qualitativeandquantitativecomposition 1mLsolutioncontains100unitsinsulindegludec*and3.6mgl..

录入者：admin 发表于：2014-12-22 　查阅全文...

GRANOCYTE 13 million IU/mL, powder and solvent for solution

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..